J&J Expected To Beat Rivals With Release Of Drug-Coated Stents

03/18/2002 | CNN · Yahoo/Reuters

Johnson & Johnson yesterday unveiled new data that show its antibiotic-coated stent prevents heart arteries from reclogging after 12 months of implantation. The company's Cordis unit is expected to market the device by 2003, six months before its rivals release their solutions. Doctors say the device will help patients needing a repeat procedure.

View Full Article in:

CNN · Yahoo/Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX